Biotechnology Havana 2010 Congress Print

Very important alert CHANGE IN CONGRESS BH2010 LOCATION

 
countdown expired
 

 

Tuesday October 19th, 2010

Time

Activity

Place

10:00-16:00

Congress Registration

Convention Palace Registration Office

 

Wednesday October 20th, 2010

Conference Room No. 3

Symposium 2: Integral Care to Diabetic Foot Ulcers. Current State.
Chairman: Dr. Jose Fernandez Montequin

Time

Activity

Speaker

Country

8:00-9:00

Delegates arrival and registration

 

 

9:00-9:30

Opening ceremony

 

 

9:30-10:25

Key Lecture, Cuban Biotechnology Development overview

Dr. Luis Herrera Martinez. President of the BH2010 Organizing Committee Congress

Cuba

10:30-11:15

Plenary Lecture: EGF: from the bench to the clinic

Dr. Jorge Berlanga.

Cuba

11:15-11:30

Coffee Break

Coffee break

 

11:30-11:50

Heberprot-P, targeting recombinant human EGF for the treatment of DFU

Dr. Manuel Raices

Cuba

12:00-12:20

Advances in Wound Care, Surgical Wound Bed Preparation and Debridement for Diabetic Foot Ulcerations, The Yale Experience

Dr. Peter Blume

United States

12:30-12:50

Clínica Pie Diabético. Hospital San Juan de Dios,
San José.

Dr. Gerardo Víquez Muñoz

Costa Rica

13:00-13:20

The Multidisciplinary Team plays an important role in improving the care of the DFU patient.

Dra Kattyuska Valero

Venezuela

13:25-13:45

Retrospective Pharmaco surveillance of UPD patients treated with Heberprot-P in Clinical Trial Assays done in Cuba.

Dr. Odalys Gonzalez Diaz

Cuba

Conference Hall No. 5

Symposium 1: Epidermal Growth Factor (EGF), its molecular biology, toxicology, pharmacogenomic. Pre clinical assays. Chairman: Dr. Jorge Berlanga

11:30-12:15

The challenging role of growth factors in the management of diabetic ulcers and the science behind the treatment".

Prof. Kelman Cohen

United States

12:20-12:50

New strategies in treating Diabetic foot ulcers

Prof. Aziz Ghahary

Canada

12:55-13:30

Pharmacogenomic study of Heberprot -P ® in xenografts nude mice with A431 squamous cells carcinoma.

Dra Isabel Guillen

Cuba

13:35-13:45

Indoleamine 2,3 dioxygenase (IDO) improve tissue repair in chronic wounds.

Dr. Claudia Chavez

Canada

 

Thursday October 21st, 2010

Conference Room No. 3

Symposium 2: Integral Care to Diabetic Foot Ulcers. Current State.
Chairman: Dr. Jose Fernandez Montequin

Time

Activity

Speaker

Country

8:00 -8:30

Delegates arrival

 

 

8:30-9:10

Plenary lecture, Intralesional human recombinant Epidermal Growth Factor (Heberprot P) for the treatment of advanced diabetic foot ulcer: from proof of concept to confirmation

Prof. Pedro Lopez Saura

Cuba

9:10-9:45

Plenary lecture, Therapeutic impact of Heberprot-P in the DFU treatment

Prof. Jose Fernandez Montequin

Cuba

9:45-10:10

The happines to keep them

Dr. Loida Gafaro de Valera

Venezuela

10:10-10:35

Controversies in the handling of osteomyelitis in Diabetic Foot Ulcer Patients

Dr. Francisco Javier Aragon Sanchez

Spain

10:35-11:00

Hyaluronan Based Dermal Substitute (Hyalomatrix PA) in the treatment of severe deep infection of diabetic foot "

Prof. Carlo Maria Ferdinando Caravaggi

Italy

11:00-11:25

Double blind study to determine the Clinical Efficacy of the Recombinant Human Epidermal Growth Factor (EGF) in Mexican population with Diabetic Foot Ulcer. A preliminary analysis.

Dr. Alfonso Lopez

Mexico

11:25-11:40

 

Coffe Break

 

11:40-12:05

Fast tissue regeneration using Heberprot-P

Dr. Gladys Jurczuck

Argentina

12:05-12:30

Conservative and operative therapy of the Charcot foot

Prof. Dr. Maximiliam Spraul

Germany

12:30-12:55

Liaison of surgeon and endocrinologist: way to success in foot salvage»

Dr.Irina V.Gurieva

Russia

12:55-13:20

Action of Heberprot-P in reducing the amputation rate in DFU treatment.

Dr. Arístides García Herrera

Cuba

13:30-13:35

Integral Care to DFU patients in the Cuban System of Primary Health Attention

Dr. Julio Esmir Baldomero

Cuba

13:35-13:45

 

 

 

 

Friday October 22nd, 2010

Conference Room No. 3

Symposium 2: Integral Care to Diabetic Foot Ulcers. Current State.
Chairman: Dr. Jose Fernandez Montequin

Time

Activity

Speaker

Country

8:00 -8:30

Delegates arrival

 

 

8:30-9:10

Practical conduct of the treatment of the diabetic foot with the use of the Heberprot-P in Cuba, R. Dominican and Algeria

Dr. Hector Alvarez

Cuba

9:10-9:35

The Foot as a marker of morbidity and mortality in diabetic patients

Prof. Alberto Piaggesi

Italy

9:35-10:00

The efficacy of neonatal skin cultured keratinocyte on healing acceleration of neuropatic diabetic foot ulcers.

Dr. Fermin Martinez Jesus

Mexico

10:00-10:25

Practical medicine experience in the administration of Heberprot-P in Diabetic Foot Ulcer Patients

Dr. Fidel Rivero

Cuba

10:25-10:50

Peripheral Vascular Disease and Limb Salvage in Diabetic Patients

Prof. Luigi Uccioli

Italy

10:50-11:15

Program for the Integral Care of UPD patients in Cuba with the use of Heberprot-P

Ing. Miriela Gil

Cuba

11:15-11:30

 

Coffe Break

 

11:30-11:55

Results in Venezuela of the Program for the Integral Care of Diabetic patients with DFU using Heberprot-P.

Dr. Natacha Sancho

Cuba

11:55-12:20

"Diabetic Foot Ulcer in Asia: Current Status and Prospect".

Prof Tang Zhengyi

China

12:20-12:45

Efficacy and safety of Heberprot-P during post-marketing phase in Cuba

Dr. Isis Yera

Cuba

12:45-13:10

Heberprot-P. An idea transformed into a product

Dr. Ernesto Lopez Mola

Cuba

13:10-13:45

 

Clossing ceremony